Alicia Jenkins
Uni of Sydney, NHMRC CTC, NSW, Australia
- This delegate is presenting an abstract at this event.
Alicia Jenkins is a Professor of Diabetes and Vascular Medicine at the NHMRC Clinical Trials Centre and The Faculty of Medicine at The University of Sydney. She provides Type 1 diabetes patient care at St. Vincent’s Health, Melbourne. She is an endocrinologist with clinical and research interests in diabetes and its complications, and the use of technology in diabetes care, including insulin pumps, glucose sensors and telehealth. With over 25 years of research experience she leads clinical and basic science research exploring diabetes and it complications, pre-diabetes, beta cell biology, biomarkers, and trialing interventions. She has over 260 publications and is Chief Editor on the textbook “Lipoproteins in diabetes mellitus”. She was on ADS Council for 8-years, on several editorial boards, and is on the Boards of Insulin For Life and the IFL Life For a Child Program.
Presentations this author is a contributor to:
Molecular markers of beta-cell mortality (#204)
2:00 PM
Ryan J Farr
ADS Basic Science Poster Discussion - Poster Award
MicroRNAs of human insulin producing cells in pancreas, gallbladder and brain (#93)
8:30 AM
Wilson Wong
ADS Basic Orals – Beta Cells
Glycaemic variability in Type 1 diabetes patients is better with continuous subcutaneous insulin infusion (CSII) therapy than with multiple daily injection (MDI) treatment. (#87)
10:00 AM
Emma Scott
ADS President's Clinical Young Investigator Award
Assessing the impact of insulin pump therapy on behaviour, mood, cognition and glycaemia in youth with Type 1 Diabetes – a randomised controlled trial (#164)
10:15 AM
Michele A O'Connell
ADS Clinical Orals - Type 1 Diabetes
A Comparison of Glycaemic Control in Adults and Adolescents With Type 1 Diabetes When Using a Closed Loop Insulin Delivery System Overnight Versus Sensor-Augmented Pump With Low Glucose Suspend At Home: A Randomised Crossover Study (#159)
9:00 AM
Amin Sharifi
ADS Clinical Orals - Type 1 Diabetes
Fenofibrate Reduces Uric Acid Levels and Gout Events in Type 2 Diabetes: Results from the Field Study (#63)
5:15 PM
Boris Waldman
ADS Clinical Orals - Type 2 Therapies
Health-worker led Retinal Imaging, Diabetes-related Eye Health Education and Lifestyle Survey Administration as a Model for Diabetic Retinopathy Screening in Indigenous Australians with Diabetes (#341)
2:00 PM
Laima Brazionis
ADS Clinical Poster Session - Diabetes Complications - Diabetic Retinopathy
Effects of Metformin Exposure during Pregnancy on the Epigenome (#319)
2:00 PM
Mugdha Joglekar
ADS Clinical Poster Session - Gestational Diabetes & Diabetes in Pregnancy